Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 1
1988 5
1989 8
1990 21
1991 13
1992 10
1993 9
1994 10
1995 21
1996 20
1997 45
1998 54
1999 83
2000 145
2001 165
2002 174
2003 183
2004 188
2005 218
2006 199
2007 197
2008 209
2009 226
2010 252
2011 249
2012 244
2013 279
2014 289
2015 297
2016 323
2017 351
2018 358
2019 370
2020 403
2021 458
2022 466
2023 460
2024 505
2025 573
2026 292

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,618 results

Results by year

Filters applied: . Clear all
Page 1
Ropivacaine.
Casati A, Santorsola R, Cerchierini E, Moizo E. Casati A, et al. Minerva Anestesiol. 2001 Sep;67(9 Suppl 1):15-9. Minerva Anestesiol. 2001. PMID: 11778088 Review.
BACKGROUND: Ropivacaine is a relatively new long-acting local anesthetic. It is a pure S(-) isomer, with a high pKa and low lipid solubility. ...Although ropivacaine has not been registered yet for spinal anesthesia, various studies show its efficacy and safety also …
BACKGROUND: Ropivacaine is a relatively new long-acting local anesthetic. It is a pure S(-) isomer, with a high pKa and low lipid sol …
[Ropivacaine].
Aguilar JL, Mendiola MA, Pedrero A. Aguilar JL, et al. Rev Esp Anestesiol Reanim. 1999 Dec;46(10):453-9. Rev Esp Anestesiol Reanim. 1999. PMID: 10670267 Review. Spanish.
This paper describes the pharmacological, pharmacokinetic and pharmacodynamic features of ropivacaine on both an experimental and clinical level. Ropivacaine is an amide-type local anesthetic whose chemical structure is related to that of mepivacaine and bupivacaine …
This paper describes the pharmacological, pharmacokinetic and pharmacodynamic features of ropivacaine on both an experimental and cli …
Ropivacaine.
Owen MD, Dean LS. Owen MD, et al. Expert Opin Pharmacother. 2000 Jan;1(2):325-36. doi: 10.1517/14656566.1.2.325. Expert Opin Pharmacother. 2000. PMID: 11249552 Review.
Ropivacaine (Naropin, AstraZeneca) is a long-acting amide local anaesthetic released for clinical use in 1996. ...This feature improves the safety of ropivacaine, and, indeed, studies have shown ropivacaine to have less cardiovascular and CNS toxicity than bu …
Ropivacaine (Naropin, AstraZeneca) is a long-acting amide local anaesthetic released for clinical use in 1996. ...This feature improv …
Ropivacaine.
Reynolds F. Reynolds F. Anaesthesia. 1991 May;46(5):339-40. doi: 10.1111/j.1365-2044.1991.tb09537.x. Anaesthesia. 1991. PMID: 2035775 Free article. No abstract available.
Ropivacaine Promotes Axon Regeneration by Regulating Nav1.8-mediated Macrophage Signaling after Sciatic Nerve Injury in Rats.
Cui Y, Wang X, Xu Y, Cao Y, Luo G, Zhao Z, Zhang J. Cui Y, et al. Anesthesiology. 2023 Dec 1;139(6):782-800. doi: 10.1097/ALN.0000000000004761. Anesthesiology. 2023. PMID: 37669448 Free PMC article.
BACKGROUND: Continuous nerve block with ropivacaine is commonly performed after repair surgery for traumatic peripheral nerve injuries. ...RESULTS: Compared to the SNT-plus-vehicle group, the sensory, motor, and sensory-motor coordination functions of the two ropivacain …
BACKGROUND: Continuous nerve block with ropivacaine is commonly performed after repair surgery for traumatic peripheral nerve injurie …
Update on ropivacaine.
Wang RD, Dangler LA, Greengrass RA. Wang RD, et al. Expert Opin Pharmacother. 2001 Dec;2(12):2051-63. doi: 10.1517/14656566.2.12.2051. Expert Opin Pharmacother. 2001. PMID: 11825334 Review.
The most important attribute of ropivacaine, however, is its increased margin of safety compared with bupivacaine when given in equal doses. ...Reduced cardiotoxicity may be a distinct characteristic of ropivacaine. A review of current literature suggests that, at c …
The most important attribute of ropivacaine, however, is its increased margin of safety compared with bupivacaine when given in equal …
Clinical application of ropivacaine in obstetrics.
Stienstra R. Stienstra R. Curr Top Med Chem. 2001 Aug;1(3):215-8. doi: 10.2174/1568026013395218. Curr Top Med Chem. 2001. PMID: 11895139 Review.
Ropivacaine is a new long-acting local anesthetic which is a pure (S)-(-)-enantiomer, with an efficacy profile similar to that of bupivacaine. Compared in equal doses, ropivacaine shows more separation between sensory and motor blockade than bupivacaine. Moreover, …
Ropivacaine is a new long-acting local anesthetic which is a pure (S)-(-)-enantiomer, with an efficacy profile similar to that of bup …
The pharmacokinetics of ropivacaine in hepatic and renal insufficiency.
Jokinen MJ. Jokinen MJ. Best Pract Res Clin Anaesthesiol. 2005 Jun;19(2):269-74. doi: 10.1016/j.bpa.2004.12.002. Best Pract Res Clin Anaesthesiol. 2005. PMID: 15966497 Review.
In patients with chronic end-stage liver disease, the peak plasma concentrations of ropivacaine after a single intravenous ropivacaine dose are similar to those in healthy subjects. However, patients with end-stage liver disease have about a 60% lower mean ropiva …
In patients with chronic end-stage liver disease, the peak plasma concentrations of ropivacaine after a single intravenous ropivac …
Epidural ropivacaine versus bupivacaine for cesarean sections: a system review and meta-analysis.
Kang T, Tao J, Wang X, Liu Y, Jin D. Kang T, et al. J Matern Fetal Neonatal Med. 2024 Dec;37(1):2313356. doi: 10.1080/14767058.2024.2313356. Epub 2024 Feb 11. J Matern Fetal Neonatal Med. 2024. PMID: 38342577 Free article.
RESULTS: We analyzed 8 RCTs with 532 parturients. 0.75% ropivacaine is associated with a shorter onset time of sensory block than 0.5% bupivacaine (SMD = -0.43, 95% CI: -0.70 to -0.17; p = .001). 0.5% ropivacaine resulted in a reduced nausea than 0.5% bupivacaine (R …
RESULTS: We analyzed 8 RCTs with 532 parturients. 0.75% ropivacaine is associated with a shorter onset time of sensory block than 0.5 …
Intrathecal ropivacaine in cesarean delivery.
Ateser RY, Kayacan N. Ateser RY, et al. Niger J Clin Pract. 2017 Oct;20(10):1322-1327. doi: 10.4103/1119-3077.219520. Niger J Clin Pract. 2017. PMID: 29192639 Clinical Trial.
The patients were randomly assigned into three groups. Group 1 received 15 mg ropivacaine 1%, Group 2 received 20 mg ropivacaine 1%, and Group 3 received 25 mg ropivacaine 1%. ...The motor block time was longer with higher doses of ropivacaine; however …
The patients were randomly assigned into three groups. Group 1 received 15 mg ropivacaine 1%, Group 2 received 20 mg ropivacaine …
7,618 results